Detail akcie MIM MONDO IGEL MED online

Business Summary: Medios AG, formerly Crevalis Capital AG, is a Germany-based company offering solutions in pharma industry. The Company covers relevant aspects of supply chain like from pharmaceutical supply and manufacture of patient-specific therapies, including blistering and others. It operates in two segments Pharmaceutical supply which focuses on pharmaceutical wholesale with finished specialty pharma (high-priced drugs for rare and chronic diseases) medications including oncology, neurology, autoimmunology, ophthalmology, infectiology, hemophilia along with offering finished medicinal products; Patient-specific therapies focusing on pharmaceutical manufacturing of patient-specific preparations such as Cytostatic infusions, Antibody therapies, Virostatic and antibiotic medications, Parenteral nutrition solutions, Investigational medicinal products are among others. Its products and services include Patient health & protection and procedures & processes for patient care and digitalization of data.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Medios AG revenues increased 9% to EUR1.53B. Net income increased 91% to EUR19.9M. Revenues reflect SPECIALTY-PHARMA TRADE segment increase of 57% to EUR1.24B, International segment increase from EUR47.3M to EUR124.2M. Net income benefited from Other income increase of 78% to EUR3.2M (income), Balancing Item - Income from Operations, increase from EUR0K to EUR2K (income).